Roble, Belko & Company, Inc Johnson & Johnson Transaction History

Roble, Belko & Company, Inc

$634 Million
Q3 2024

A detailed history of Roble, Belko & Company, Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 3,238 shares of JNJ stock, worth $502,440. This represents 0.08% of its overall portfolio holdings.

Number of Shares

3,238

Previous 3,234 0.12%

Holding current value

$502,440

Previous $473,000 10.99%

% of portfolio

0.08%

Previous 0.08%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$145.48 - $167.38 $581 - $669	4 Added 0.12%	3,238 $525,000
Q4 2023 Feb 01, 2024	BUY	$145.6 - $158.88 $228,883 - $249,759	1,572 Added 94.58%	3,234 $507,000
Q3 2023 Nov 01, 2023	SELL	$155.75 - $174.48 $8,722 - $9,770	-56 Reduced 3.26%	1,662 $259,000
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $4,531 - $5,407	-30 Reduced 1.72%	1,718 $266,000
Q4 2022 Feb 08, 2023	BUY	$160.2 - $179.79 $66,963 - $75,152	418 Added 31.43%	1,748 $309,000
Q2 2022 Aug 10, 2022	SELL	$168.19 - $186.01 $16,819 - $18,601	-100 Reduced 6.99%	1,330 $236,000
Q1 2022 May 06, 2022	SELL	$158.14 - $179.59 $31,627 - $35,918	-200 Reduced 12.27%	1,430 $253,000
Q4 2021 Feb 07, 2022	BUY	$155.93 - $173.01 $254,165 - $282,006	1,630 New	1,630 $279,000
Q3 2021 Nov 03, 2021	SELL	$161.5 - $179.47 $247,095 - $274,589	-1,530 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$153.07 - $170.48 $122,456 - $136,384	800 Added 109.59%	1,530 $251,000
Q3 2020 Nov 10, 2020	SELL	$140.38 - $153.83 $285,252 - $312,582	-2,032 Reduced 73.57%	730 $109,000
Q2 2020 Aug 10, 2020	BUY	$128.81 - $155.51 $26,792 - $32,346	208 Added 8.14%	2,762 $388,000
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $201,052 - $221,119	1,533 Added 150.15%	2,554 $356,000
Q2 2018 Aug 08, 2018	SELL	$119.4 - $131.76 $35,223 - $38,869	-295 Reduced 22.42%	1,021 $124,000
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $19,015 - $22,517	152 Added 13.06%	1,316 $169,000
Q4 2017 Jan 30, 2018	BUY	$131.22 - $143.62 $57,080 - $62,474	435 Added 59.67%	1,164 $163,000
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $94,383 - $98,692	729	729 $95,000

Others Institutions Holding JNJ

# of Institutions

4,271

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $406B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roble, Belko & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Roble, Belko & Company, Inc with notifications on news.

Account

Roble, Belko & Company, Inc Johnson & Johnson Transaction History